-
Honokiol at the Immunometabolism–Inflammation Interface
2026-08-13
A translational framework for using Honokiol to interrogate the relationship between NF-κB signaling, oxidative stress, tumor angiogenesis, and the metabolic flexibility of antitumor CD8+ T cells.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-12
Saito and colleagues developed an accessible three-dimensional culture strategy for generating intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be expanded, cryopreserved, and differentiated into intestinal epithelial cells with cytochrome P450 and transporter activities relevant to human pharmacokinetic studies.
-
Urolithin A: Designing Metabolic Fibrosis Assays
2026-08-12
Urolithin A can extend mitochondrial quality-control studies into more rigorous metabolic fibrosis assays. This article connects mitophagy biology with glutamine-dependent hepatic stellate-cell activation while separating established evidence from testable experimental hypotheses.
-
Ruthenium Red: A Causal Tool for Calcium Signaling
2026-08-11
Ruthenium Red is a Ca2+ transport inhibitor for separating calcium-dependent effects from cytoskeletal mechanotransduction and autophagy. This guide connects membrane transport biology with practical assay design, controls, and interpretation limits.
-
Sumatriptan Succinate in Translational Migraine Research
2026-08-11
Sumatriptan is more than a clinical migraine therapy: it is a receptor-defined tool for studying serotonergic signaling, neurovascular biology, and inflammation. This thought-leadership guide connects mechanism, assay design, metabolic considerations, and pediatric emergency-department evidence to help translational researchers use the compound with greater rigor.
-
Hoechst 33342 Nuclear Stain Workflow
2026-08-10
Build reproducible live-cell, fixed-cell, and flow cytometry assays with Hoechst 33342 nuclear stain while preserving compatibility with mitochondrial and senescence readouts. This practical workflow uses the 1 mg/mL reagent to improve cell counting, nuclear morphology analysis, and normalization in dermal fibroblast studies.
-
Azilsartan Medoxomil: Efficacy and Safety Meta-analysis
2026-08-09
This 2024 systematic review and meta-analysis integrates randomized evidence on azilsartan medoxomil for hypertension, evaluating both blood-pressure reduction and adverse events. The findings support greater pressure lowering at 40 and 80 mg than control therapy, while overall tolerability remained broadly comparable, including in the limited diabetes evidence base.
-
Mifepristone (RU486) Research Workflows
2026-08-08
Mifepristone (RU486) provides a practical way to perturb progesterone receptor signaling across cancer, reproductive, and sperm-function assays. This workflow combines product-backed concentration ranges with receptor-dependence controls, compartment-aware experimental design, and troubleshooting strategies for reproducible research.
-
Multiple Myeloma Cell Lines: Mutational Drivers
2026-08-07
This 2019 Theranostics study used whole-exome sequencing to define coding mutations across a genetically diverse panel of human multiple myeloma cell lines and connect altered genes with oncogenic pathways and drug response. Its main practical contribution is a molecular framework for selecting better-characterized models for myeloma biology, resistance studies, and genotype-informed screening.
-
EZ Cap™ Firefly Luciferase mRNA: Optimizing Bioluminescent A
2026-08-07
EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure redefines reporter assay sensitivity and stability, empowering advanced mRNA delivery and in vivo imaging. This article translates the latest experimental breakthroughs into actionable workflow enhancements, troubleshooting guidance, and comparative insights for molecular biology researchers.
-
Dual-Action Inhibition of p38α MAPK: Impact on Dephosphoryla
2026-08-06
Stadnicki et al. reveal that certain p38α MAP kinase inhibitors not only block kinase activity but also accelerate dephosphorylation by inducing a specific activation loop conformation. This dual-action mechanism could enhance specificity and potency in targeting inflammatory signaling pathways relevant to diseases like rheumatoid arthritis.
-
hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic S
2026-08-06
This study introduces a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids, offering a physiologically relevant in vitro model for pharmacokinetic and drug metabolism research. The findings improve upon conventional models by providing long-term proliferative organoids that recapitulate intestinal cell diversity and metabolic function, supporting more predictive drug absorption and metabolism assays.
-
Lipid Nanoparticle Composition Shapes Tissue-Targeted T Cell
2026-08-05
This study demonstrates that the lipid composition of mRNA-loaded nanoparticles critically determines their systemic trafficking and subsequent tissue-specific immune responses after intramuscular injection. These findings provide a mechanistic foundation for designing vaccines that induce durable, organ-focused immunity by tuning delivery vehicle properties.
-
JAK Inhibitors Block Sensory Neuron Activation in RA: Mechan
2026-08-05
This study reveals that JAK inhibitors directly block synovial fluid-induced activation of human sensory neurons in rheumatoid arthritis (RA), explaining their superior analgesic effect over anti-TNF agents. The findings highlight the JAK/STAT pathway’s role in pain transmission and provide a molecular rationale for targeted pain management in RA.
-
Dihydroartemisinin: Molecular Insights and Evolving Research
2026-08-04
Explore the unique molecular mechanisms and research applications of Dihydroartemisinin, a potent Artemisia plant extract. This in-depth analysis reveals advanced assay considerations and differentiates Dihydroartemisinin's role as an mTOR pathway inhibitor from alternative antimalarial strategies.